Inflammasome Activation Triggers Systemic Coagulation in Sepsis
脓毒症中炎症小体激活引发全身凝血
基本信息
- 批准号:10645452
- 负责人:
- 金额:$ 42.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:ApoptosisBacteriaBacterial InfectionsBlood Coagulation DisordersBlood Coagulation FactorBone MarrowBurkholderiaCASP1 geneCellsCessation of lifeClinicalCoagulation ProcessComplicationConsumptionDataDevelopmentDiseaseDisseminated Intravascular CoagulationEscherichia coliFamilyFibrinogenFlagellinFunctional disorderGoalsGram-Negative BacteriaIn VitroInfectionInflammasomeInfusion proceduresInjectionsInterventionKnockout MiceLeadLinkModelingMolecularMorbidity - disease rateMusMyelogenousNeedlesOrganOutcomePathway interactionsPatientsPeripheralPhagocytosisPhysiologicalPlasmaPlayProteinsProthrombin time assayPseudomonas aeruginosaReagentResearch Project GrantsRodRoleSalmonellaSepsisSeptic ShockTestingThrombocytopeniaThromboplastinThrombosisThrombusTissuesType III Secretion System PathwayWorkantithrombin III-protease complexbasececal ligation puncturedriving forcein vivoinsightintravenous injectionmacrophagemonocytemortalitymouse modelmultidisciplinarynew therapeutic targetprotein Erelease factorseptic patientstargeted treatment
项目摘要
Abstract
Septic shock is invariably associated with systemic coagulation leading to thrombus formation. Sepsis-related
organ dysfunction has been attributed to microvascular thrombosis. Mortality rate doubles in septic patients
with disseminated intravascular coagulation (DIC). DIC is even considered as a sign that “death is coming”.
Previous studies have demonstrated the important roles of tissue factor (TF) in sepsis-associated DIC.
However, the mechanism leading to TF release, which triggers systemic coagulation in sepsis, is unknown.
Recent in vitro studies revealed that bacterial components (flagellin, the rod protein of the type III secretion
system (T3SS), or LPS) induce programmed cell death (called pyroptosis) of macrophages through activation
of inflammasome pathways. We show that intravenous injection of a T3SS rod protein E. coli, EprJ, induced
depletion of peripheral monocytes and macrophages in tissues. Importantly, injection of EprJ or LPS, which
elicit canonical and noncanonical inflammasome activation, respectively, induced systemic coagulation
activation, as evident by prolonged prothrombin time (PT) due to increased consumption of coagulation factors,
thrombocytopenia, increased plasma levels of thrombin-antithrombin complex (TAT), and reduced plasma
fibrinogen levels. Thus, our findings made connections between the in vitro and in vivo observations and
suggested monocyte/macrophage pyroptosis as a trigger of DIC in sepsis. The goal of this application is to
delineate the underlying mechanisms by which inflammasome activation and pyroptosis trigger DIC in sepsis.
Specific Aim 1 will establish inflammasome activation and pyroptosis as a common mechanism for DIC
induced by bacterial infection. The working hypothesis is that bacteria and bacterial components from different
strains elicit DIC through Inflammasome activation and pyroptosis. We will use a combination of various
deficient mice to elucidate the role of inflammasome activation and pyroptosis in DIC elicited by Gram-negative
bacteria. Specific Aim 2 is to identify the molecular mechanism of TF release from macrophages following
inflammasome activation. We will also use the myeloid-specific TF knockout mice and a low TF mouse model
to elucidate whether DIC elicited by the bacterial components depends on release of TF from macrophages.
Specific Aim 3 will demonstrate the role of inflammasome activation in sepsis-associated coagulopathy. We will
use the cecal ligation and puncture (CLP) sepsis model and bacterial infusion sepsis model to investigate the
role of inflammasome activation and pyroptosis in coagulation. Completion of the proposed studies will
demonstrate the molecular mechanism of systemic coagulation is sepsis. Such findings would have profound
ramifications for the identification of new drug targets for DIC, the deadly complication of sepsis.
抽象的
脓毒性休克总是与导致脓毒症相关血栓形成的全身凝血有关。
器官功能障碍归因于微血管血栓形成,脓毒症患者的死亡率加倍。
弥散性血管内凝血(DIC)甚至被认为是“死亡即将来临”的征兆。
先前的研究已经证明了组织因子(TF)在脓毒症相关 DIC 中的重要作用。
然而,导致 TF 释放并引发脓毒症全身凝血的机制尚不清楚。
最近的体外研究表明,细菌成分(鞭毛蛋白,III 型分泌物的杆蛋白)
系统(T3SS)或 LPS)通过激活诱导巨噬细胞程序性细胞死亡(称为细胞焦亡)
我们发现静脉注射大肠杆菌 T3SS 杆状蛋白 EprJ 可诱导炎症小体途径的发生。
重要的是,注射 EprJ 或 LPS,消除组织中的外周单核细胞和巨噬细胞。
分别引发典型和非典型炎症小体激活,诱导全身凝血
激活,如由于凝血因子消耗增加而导致凝血酶原时间(PT)延长,
血小板减少症、血浆凝血酶-抗凝血酶复合物 (TAT) 水平升高以及血浆水平降低
因此,我们的研究结果将体外和体内观察结果联系起来。
建议单核细胞/巨噬细胞焦亡作为败血症中 DIC 的触发因素。
描述脓毒症中炎症小体激活和细胞焦亡触发 DIC 的潜在机制。
具体目标 1 将确定炎症小体激活和细胞焦亡作为 DIC 的常见机制
由细菌感染引起的工作假设是细菌和细菌成分来自不同的细菌。
菌株通过炎症小体激活和细胞焦亡引发 DIC。我们将使用各种组合。
缺陷小鼠阐明炎症小体激活和细胞焦亡在革兰氏阴性菌引起的 DIC 中的作用
具体目标 2 是确定巨噬细胞释放 TF 的分子机制。
我们还将使用骨髓特异性 TF 敲除小鼠和低 TF 小鼠模型。
阐明细菌成分引起的 DIC 是否依赖于巨噬细胞释放 TF。
具体目标 3 将证明炎症小体激活在脓毒症相关凝血病中的作用。
使用盲肠结扎穿刺(CLP)脓毒症模型和细菌输注脓毒症模型来研究
炎症体激活和焦亡在凝血中的作用将完成拟议的研究。
证明败血症是全身性凝血的分子机制,这样的发现将具有深远的意义。
确定 DIC 新药物靶点的影响,DIC 是脓毒症的致命并发症。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Donnan Potential across the Outer Membrane of Gram-Negative Bacteria and Its Effect on the Permeability of Antibiotics.
穿过革兰氏阴性菌外膜的唐南电位及其对抗生素渗透性的影响。
- DOI:
- 发表时间:2021-06-11
- 期刊:
- 影响因子:0
- 作者:Alegun, Olaniyi;Pandeya, Ankit;Cui, Jian;Ojo, Isoiza;Wei, Yinan
- 通讯作者:Wei, Yinan
Calcium Ion Chelation Preserves Platelet Function During Cold Storage.
钙离子螯合可在冷藏期间保留血小板功能。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Xiang, Binggang;Zhang, Guoying;Zhang, Yan;Wu, Congqing;Joshi, Smita;Morris, Andrew J;Ware, Jerry;Smyth, Susan S;Whiteheart, Sidney W;Li, Zhenyu
- 通讯作者:Li, Zhenyu
Insight into the AcrAB-TolC Complex Assembly Process Learned from Competition Studies.
从竞争研究中深入了解 AcrAB-TolC 复杂的组装过程。
- DOI:
- 发表时间:2021-07-08
- 期刊:
- 影响因子:0
- 作者:Rajapaksha, Prasangi;Ojo, Isoiza;Yang, Ling;Pandeya, Ankit;Abeywansha, Thilini;Wei, Yinan
- 通讯作者:Wei, Yinan
Inflammasome activation and pyroptosis mediate coagulopathy and inflammation in Salmonella systemic infection.
炎性小体激活和细胞焦亡介导沙门氏菌全身感染中的凝血病和炎症。
- DOI:
- 发表时间:2023-10
- 期刊:
- 影响因子:6.7
- 作者:Pandeya, Ankit;Zhang, Yan;Cui, Jian;Yang, Ling;Li, Jeffery;Zhang, Guoying;Wu, Congqing;Li, Zhenyu;Wei, Yinan
- 通讯作者:Wei, Yinan
Pyroptosis-Induced Inflammation and Tissue Damage.
焦亡引起的炎症和组织损伤。
- DOI:
- 发表时间:2022-02-28
- 期刊:
- 影响因子:5.6
- 作者:Wei, Yinan;Yang, Ling;Pandeya, Ankit;Cui, Jian;Zhang, Yan;Li, Zhenyu
- 通讯作者:Li, Zhenyu
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHENYU Li其他文献
ZHENYU Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHENYU Li', 18)}}的其他基金
A novel mechanism of immunosuppression in sepsis: Depletion of monocytes and macrophages
脓毒症免疫抑制的新机制:单核细胞和巨噬细胞的耗竭
- 批准号:
10436162 - 财政年份:2019
- 资助金额:
$ 42.95万 - 项目类别:
A novel mechanism of immunosuppression in sepsis: Depletion of monocytes and macrophages
脓毒症免疫抑制的新机制:单核细胞和巨噬细胞的耗竭
- 批准号:
10194546 - 财政年份:2019
- 资助金额:
$ 42.95万 - 项目类别:
A novel mechanism of immunosuppression in sepsis: Depletion of monocytes and macrophages
脓毒症免疫抑制的新机制:单核细胞和巨噬细胞的耗竭
- 批准号:
10020416 - 财政年份:2019
- 资助金额:
$ 42.95万 - 项目类别:
A novel mechanism of immunosuppression in sepsis: Depletion of monocytes and macrophages
脓毒症免疫抑制的新机制:单核细胞和巨噬细胞的耗竭
- 批准号:
10605060 - 财政年份:2019
- 资助金额:
$ 42.95万 - 项目类别:
Crosstalk between membrane traffic proteins and integrin activation
膜运输蛋白和整合素激活之间的串扰
- 批准号:
8837170 - 财政年份:2014
- 资助金额:
$ 42.95万 - 项目类别:
PLATELET ACTIVATION WITH OBESITY PROMOTES ATHEROTHROMBOTIC VASCULAR EVENTS
肥胖引起的血小板激活促进动脉粥样硬化性血管事件
- 批准号:
8360249 - 财政年份:2011
- 资助金额:
$ 42.95万 - 项目类别:
PLATELET ACTIVATION WITH OBESITY PROMOTES ATHEROTHROMBOTIC VASCULAR EVENTS
肥胖引起的血小板激活促进动脉粥样硬化性血管事件
- 批准号:
8174559 - 财政年份:2010
- 资助金额:
$ 42.95万 - 项目类别:
PLATELET ACTIVATION WITH OBESITY PROMOTES ATHEROTHROMBOTIC VASCULAR EVENTS
肥胖引起的血小板激活促进动脉粥样硬化性血管事件
- 批准号:
7960386 - 财政年份:2009
- 资助金额:
$ 42.95万 - 项目类别:
相似国自然基金
基于共价有机框架的噬菌体-光催化协同靶向抗菌策略用于顽固性细菌感染的研究
- 批准号:22378279
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
“持续化学发光与多效抗菌”复合探针的构筑及其关节假体周围感染细菌的检测与灭活研究
- 批准号:82302646
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道类器官模型探讨T6SS在细菌感染过程中对宿主MAPK信号通路的调控作用及机制研究
- 批准号:32300597
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于气味感知和知识迁移的伤口感染细菌精准识别方法研究
- 批准号:62301102
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
双特异性抗体囊泡对胞内细菌感染的免疫综合机制研究
- 批准号:82304366
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Effector-triggered immunity against Legionella pneumophila in dendritic cells
树突状细胞中针对嗜肺军团菌的效应子触发免疫
- 批准号:
10753211 - 财政年份:2023
- 资助金额:
$ 42.95万 - 项目类别:
Mucosal Immune Defense Mechanisms of the Urinary Bladder
膀胱粘膜免疫防御机制
- 批准号:
10587639 - 财政年份:2023
- 资助金额:
$ 42.95万 - 项目类别:
Central role of Caspase-8 in control of host tolerance and resistance mechanisms in pulmonary macrophage populations during severe respiratory infections
Caspase-8 在严重呼吸道感染期间肺巨噬细胞群宿主耐受和抵抗机制中的核心作用
- 批准号:
10668787 - 财政年份:2023
- 资助金额:
$ 42.95万 - 项目类别:
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia
仿生巨噬细胞膜包被的纳米海绵:一种治疗多重耐药铜绿假单胞菌和鲍曼不动杆菌医院相关肺炎的新疗法
- 批准号:
10674406 - 财政年份:2023
- 资助金额:
$ 42.95万 - 项目类别: